REL


Also found in: Dictionary, Acronyms, Encyclopedia, Wikipedia.

REL

A gene on chromosome 2p13-p12 that encodes a member of the Rel/NF-kappaB family of transcription factors (as do RELA, RELB, and NFKB2), which is distinguished by the presence of an N-terminal Rel homology domain.
 
Significance
c-Rel overexpression causes downregulation of EPHB2, an ephrin receptor tyrosine kinase in the intestine, and is associated with a poor prognosis in colorectal carcinoma.
References in periodicals archive ?
In its final judgment on Tuesday, the ATE sided with the DERC's contention that the REL was effectively a middleman in the deal, as it bought the transformers from the manufacturer, and it wasn't entitled for such huge profit.
However, the end appears to be in sight, and maybe REL will be able to move on swiftly.
More information on REL is available: by phone at (770) 225-7300; by e-mail at info@relconsultancy.
Thorpe added: "While the BHA goes about promoting the image of British racing, REL will concentrate on growing the business.
The other vacancy should be filled within weeks, according to REL board member and Racehorse Owners' Association president Paul Dixon, who said an independent chairman had been identified and would be named shortly.
Working collaboratively with customers and suppliers can be a very effective way to boost cash flow and manage working capital for the entire enterprise value chain," said Bill Beech, principal at REL Consultancy Group.
According to the REL study, typical companies potentially miss quarterly working capital forecasts (including inventory, receivables, and payables) by up to 23 percent, which amounts to up to $600 million for a typical Global 1000 company (with $29 billion annual revenue).
After the nationalisation of SNS REL on 1 February 2013, the Minister of Finance announced that the real estate and real estate loan portfolio would be separated.
That said, it is important that REL is seen as an essential part of the administrative and financial structure of British racing going forward.
pharmaceutical companies are literally leaving money on the table at a time when the industry as a whole is struggling in the face of disappointing single-digit growth, a lack of new products to replace drugs coming off patent, increasing competition and shrinking margins," said Stephen Payne, chief executive officer of REL Consultancy Group.
companies up to $100 million each year by making it significantly harder to collect from customers quickly, according to new research from REL Consulting, a division of The Hackett Group, Inc.
The European Commission has found the restructuring plan of the Dutch bank insurance company SNS REL to be in line with EU state aid rules.